An optimistic view for quantifying mRNA in post-mortem human brain

Molecular Brain Research

Volumn 116, Issue 1-2, 2003, Pages 7-16

  Preece, Paul ^a   Virley, David J ^b   Costandi, Moheb ^c   Coombes, Robert ^d   Moss, Stephen J ^d   Mudge, Anne W ^d   Jazin, Elena ^e   Cairns, Nigel J ^f  

^a Quantuum   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UPPSALA UNIVERSITY   (Sweden)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Human brain; mRNA; Quantification; TaqMan

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CADAVER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; RNA TRANSCRIPTION; SAMPLING; STATISTICAL SIGNIFICANCE;

EID: 0043021953     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00208-0     Document Type: Article

References (35)

1. Altschul S., Gish W., Miller W., Myers E., Lipman D. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
2. Barton A.J., Pearson R.C., Najlerahim A., Harrison P.J. Pre- and postmortem influences on brain RNA. J. Neurochem. 61:1993;1-11.
3. Bond B.C., Virley D.J., Cairns N.J., Moore G., Moss S.J., Mudge A.W., Walsh F.W., Jazin E., Preece P. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Mol. Brain Res. 106:2002;101-116.
4. Castensson A., Emilsson L., Preece P., Jazin E. High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10:2000;1219-1229.
5. Clark A.W., Krekoski C.A., Parhad I.M., Liston D., Julien J.P., Hoar D.I. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann. Neurol. 25:1989;331-339.
6. Cochran W.G., Cox G.M. Experimental Designs. 2nd Edition: 1957;Wiley, New York.
7. Cummings T.J., Strum J.C., Yoon L.W., Szymanski M.H., Hulette C.M. Recovery and expression of messenger RNA from postmortem human brain tissue. Mod. Pathol. 14:(11):2001;1157-1161.
8. Ehrlich G.D., Greenberg S.J. PCR in Clinical Diagnostics. PCR-based Diagnostics in Infectious Disease. 1994;Blackwell, Oxford. pp. 6-7.
9. D.H. Gelfand, P.M. Holland, R.K. Saiki, R.M. Watson, US Patent No. 5210015, 1993.
10. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
11. Griffin W.S.T., Stanley L.C. Glial activation as a common denominator in neurodegenerative disease: a hypothesis in neuropathophysiology. Biology and Pathology of Astrocyte-Neuron Interactions. 1993;359-381 Plenum Press, New York.
12. Hardy J.A., Wester P., Winblad B., Gezelius C., Bring G., Eriksson A. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61:1985;253-264.
13. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W., McDonald B., Pearson R.C. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200:1995;151-154.
14. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
15. Higuchi R., Dollinger G., Walsh P.S., Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology. 10:1992;413-417.
16. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR: Real time monitoring of DNA amplification reactions. Biotechnology. 11:1993;1026-1030.
17. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. Detection of specific polymerase chain reaction product by utilitzing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 88:1991;7276-7280.
18. Hulette C., Mirra S., Wilkinson W., Heyman A., Fillenbaum G., Clark C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 45:1995;1991-1995.
19. Johnson S.A., McNeill T., Cordell B., Finch C.E. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science. 248:1990;854-857.
20. Johnson S.A., Pasinetti G.M., May P.C., Ponte P.A., Cordell B., Finch C.E. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp. Neurol. 102:1988;264-268.
21. Johnson S.A., Rogers J., Finch C.E. APP-695 transcript prevalence is selectively reduced during Alzheimer's disease in cortex and hippocampus but not in cerebellum. Neurobiol. Aging. 10:1989;755-760.
22. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28:1995;311-318.
23. Lee L.G., Connell C.R., Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21:1993;3761-3766.
24. Lie Y.S., Petropoulos C.J. Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9:1998;43-48.
25. Livak K.J., Flood S.J.A., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Applic. 4:1995;357-362.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
27. Mirnics K., Middleton F., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
28. beta amyloid protein precursor containing the Kunitz protease inhibitory domain. J. Biol. Chem. 273:1998;5013-5019.
29. Preece P., Virley D.J., Bond B.C., Cairns N.J. Quantifying fraction-fold changes of mRNA in transient middle cerebral artery occlusion (tMCAO) in rat brain. Neuropathol. Appl. Neurobiol. 27:2001;165-166.
30. Rockenstein E.M., McConlogue L., Tan H., Power M., Masliah E., Mucke L. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270:1995;28257-28267.
31. Ross B.M., Knowler J.T., McCulloch J. On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J. Neurochem. 58:1992;1810-1819.
32. Spanakis E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res. 21:1993;3809-3819.
33. Spanakis E., Brouty-Boye D. Evaluation of quantitative variation in gene expression. Nucleic Acids Res. 22:1994;799-806.
34. Weisinger G., Gavish M., Mazurika C., Zinder O. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochim. Biophys. Acta. 1446:1999;225-232.
35. Zhong H., Simons J.W. Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259:1999;523-526.